Belarus vs Senegal: Treatment success rate for patients treated for MDR-TB
Belarus
85.0%
in 2022
Senegal
84.0%
in 2022
Belarus rank
35th
Senegal rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Belarus
- Senegal
How they compare
Belarus currently reports 85.0% against 84.0% in Senegal, a difference of 1.0%.
The two have swapped places 1 time across 12 shared years of data; in 2010 it was Senegal ahead.
Belarus ranks 35th and Senegal ranks 38th of 163 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.2% | 80.4% | 19.2% | Senegal |
| 2020s | 82.0% | 84.0% | 2.0% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Belarus or Senegal?
- Belarus, at 85.0% against 84.0% in Senegal as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Belarus and Senegal?
- 1.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Senegal?
- 12 years are reported by both, from 2010 to 2022.
- How do Belarus and Senegal rank globally for treatment success rate for patients treated for mdr-tb?
- Belarus ranks 35th and Senegal ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.